← Eichor
Study identifier: NCT06145516 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Promoting Sleep to Alleviate Pain - Arthroplasty

Condition: Osteoarthritis, Knee · Osteoarthritis, Hip · Insomnia  ·  Sponsor: Uppsala University

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

PROSAP-A is a perioperative randomized, controlled trial with a 12-month follow-up period after total knee arthroplasty (TKA) or total hip arthroplasty (THA), aiming to investigate both acute and long-term postoperative effects of preoperative sleep-promotion. Participants with clinically significant insomnia symptoms will be randomized to a brief, hybrid version of cognitive behavioral therapy for insomnia (CBT-I) or sleep education therapy, administered over a 4-week period, prior to surgery. The primary objective is to evaluate effects of preoperative sleep-promotion on acute postoperative pain control. Secondary objectives include evaluation of postoperative sleep, recovery, mental health, cognitive function and alterations in blood biomarkers.

This description comes directly from the study's public registry record.

Talk to the study team

Martin F Bjurström, MD, PhD  ·  +46739512728  ·  martin.flores.bjurstrom@uu.se

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Surgical Sciences, Uppsala UniversityUppsala, Uppland, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06145516